This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.
Five U.S. scientists have been awarded $1.25 million each to carry out high-risk, high-reward cancer immunology research with potential to transform cancer treatment.
30 days of immunotherapy education and awareness programming for patients, caregivers, and the general public celebrating advances in immuno-oncology research and treatment
Cancer Research Institute has published a comprehensive analysis of the current clinical trial landscape of anti PD-1/L1 immune checkpoint inhibitors.
The Cancer Research Institute has published an updated global immuno-oncology landscape analysis highlighting a robust pipeline marked by rapid growth.
The study explores a potential non-invasive approach to identify tumor mutations.
Contact Us
Cancer Research Institute | National Headquarters 29 Broadway, Floor 4 | New York, NY 10006-3111
800-992-2623212-832-9376Staff Directory
Cancer is not “one-size-fits-all” and neither are its treatments, especially when it comes to immunotherapy. Learn how CRI is helping more people overcome cancer.
Immunotherapy updates from the world's largest cancer conference, the Annual Meeting of the American Society for Clinical Oncology (ASCO).